Multiple Myeloma or Lymphoma: Study of CLR 131 in Relapsed or Refractory Select B-Cell
Malignancies
Research Question:
Is the study drug, CLR 131, effective for the treatment of multiple myeloma or certain
lymphomas?
Basic Study Information
Purpose:
This research is being done to help us determine if the study drug is safe and can
be tolerated for the treatment of multiple myeloma or certain lymphomas.
Location: Cancer Center
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02952508?term=02952508&rank=1
Study Reference #: IMMY17015
Lead Researcher (Principal Investigator)
Lead Researcher: Brea Lipe
Study Contact Information
Study Coordinator: Andrew Bui
Phone: (585) 276-4405
Email: Andrew_Bui@URMC.Rochester.edu
Additional Study Details
Learn More About These Conditions
More information about Lymphoma
More information about Multiple Myeloma
Trial Not Found
The study you are looking for is not active at this time.
Return to Search